Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Vitamin D insufficiency and chronic diseases: Hype and reality.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Glial influence on the blood brain barrier.
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Voltage-gated potassium channel antibodies: Game over.
Fluoxetin Upregulates Connexin 43 Expression in Astrocyte.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
Missing links in multiple sclerosis etiology. A working connecting hypothesis.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Neuroimmunological diseases and pregnancy.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
Pages
« first
‹ previous
…
291
292
293
294
295
296
297
298
299
…
next ›
last »